RxDoctor Payments Data

Joseph Curry, MD

Otolaryngology · Philadelphia, PANPI 1043427172

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (58.9%), education and travel and lodging — rather than concentrated in one kind of arrangement. Sanofi accounts for 63.3% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $13,455 and has fallen 84.3% since, to $2,118 in 2025. Among otolaryngology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,856in general payments, 2019–2025

Across 41 payments — averaging $484.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$13K
  • Intuitive Surgical$4K
  • Medical Device Business Services, Inc.$2K
  • AstraZeneca$859
  • Baxter Healthcare$687
  • Medtronic$175
  • plus $472 from 5 others
$2,016,578in research payments, 2019–2025

Across 41 payments — averaging $49,185 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$745K
  • Regeneron$740K
  • Sanofi US Services Inc.$531K

What the payments were for

  • Consulting fees$11,70359%
  • Travel & lodging$2,59413%
  • Food & beverage$2,05910%
  • Education$3,50018%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,856 in reported general payments places this provider in the 95th percentile of 456 otolaryngology providers in Pennsylvania.

See all otolaryngology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$322,762
Medicare patients
459
Services billed
1,474

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pilocarpine Hcl18$2,079
Lidocaine Hcl ViscousLidocaine Hcl21$388
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav27$290
Gabapentin21$265
Methylprednisolone32$202
Fluticasone Propionate13$163
Chlorhexidine Gluconate40$112
Omeprazole17$57
Oxycodone Hcl20$46

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →